Antiseptics in the era of bacterial resistance: A focus on povidone iodine

Clinical Practice

Volumn 10, Issue 5, 2013, Pages 579-592

  Lachapelle, Jean Marie ^a   Castel, Olivier ^b   Casado, Alejandro Fueyo ^c   Leroy, Bernard ^a   Micali, Giuseppe ^d   Tennstedt, Dominique ^a   Lambert, Julien ^e  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d UNIVERSITY OF CATANIA   (Italy)

^e ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; OCTENIDINE; POLYHEXANIDE; POVIDONE IODINE; UNCLASSIFIED DRUG;

ALLERGENICITY; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTISEPSIS; CYTOTOXICITY TEST; DRUG BINDING; DRUG INDICATION; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; DRUG USE; FUNGICIDAL ACTIVITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION PREVENTION; MICROBIAL COLONIZATION; NONHUMAN; PATCH TEST; PREOPERATIVE CARE; REVIEW; SKIN DECONTAMINATION; SKIN FUNCTION; SKIN INFECTION; WOUND; WOUND INFECTION;

EID: 84883254633     PISSN: 20449038     EISSN: 20449046     Source Type: Journal    
DOI: 10.2217/cpr.13.50     Document Type: Review

References (85)

1. Hubner NO, Kramer A. Review on the efficacy, safety and clinical applications of polihexanide, a modern wound antiseptic. Skin Pharmacol. Physiol. 23(Suppl.), S17-S27 (2010
2. How to Treat Skin Infections in the Era of Bacterial Resistance? Del Guidice P, Lachapelle JM, Lambert J. (Eds). Maca-Cloetens, Bruxelles, Belgium (2012
3. Durani P, Leaper D. Povidone-iodine: Use in hand disinfection, skin preparation and antiseptic irrigation. Int. Wound J. 5(3), 376-387 (2008
4. Milstone AM, Passaretti CL, Perl TM. Chlorhexidine: Expanding the armamentarium for infection control and prevention. Clin. Infect. Dis. 46(2), 274-281 (2008
5. Hubner NO, Siebert J, Kramer A. Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds. Skin Pharmacol. Physiol. 23(5), 244-258 (2010
6. McDonnell G, Russell AD. Antiseptics and disinfectants: Activity, action, and resistance. Clin. Microbiol. Rev. 12(1), 147-179 (1999
7. Kawana R, Kitamura T, Nakagomi O et al. Inactivation of human viruses by povidone iodine in comparison with other antiseptics. Dermatology 195(Suppl. 2), S29-S35 (1997
8. Ito H, Ito T, Hikida M et al. Outbreak of highly pathogenic avian influenza in Japan and anti-influenza virus activity of povidone-iodine products. Dermatology 212(Suppl. 1), S115-S118 (2006
9. Wutzler P, Sauerbrei A, Klocking R, Brogmann B, Reimer K. Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine. Antiviral Res. 54(2), 89-97 (2002
10. Michel D, Zach GA. Antiseptic efficacy of disinfecting solutions in suspension test in vitro against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli in pressure sore wounds after spinal cord injury. Dermatology 195(Suppl. 2), S36-S41 (1997
11. Block C, Robenshtok E, Simhon A, Shapiro M. Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test. J. Hosp. Infect. 46(2), 147-152 (2000
12. Kunisada T, Yamada K, Oda S, Hara O. Investigation on the efficacy of povidone-iodine against antiseptic-resistant species. Dermatology 195(Suppl. 2), 14-18 (1997
13. McLure AR, Gordon J. In-vitro evaluation of povidone-iodine and chlorhexidine against methicillin-resistant Staphylococcus aureus. J. Hosp. Infect. 21(4), 291-299 (1992
14. Yasuda T, Yoshimura S, Katsuno Y et al. Comparison of bactericidal activities of various disinfectants against methicillin-sensitive Staphylococcus aureus and methicillin-resistant Staphylococcus aureus. Postgrad. Med. J. 69(Suppl. 3), S66-S69 (1993
15. Neil G, Hanslo D, Buccimazza S, Kibel M. Control of the carrier state of scalp dermatophytes. Pediatr. Infect. Dis. 9(1), 57-58 (1990
16. Pierard-Franchimont C, Arrese JE, Camacho MA, Piérard GE. Experimental dermatophyte infection abated by povidone-iodine: Assessment by computerized-assisted corneofungimetry. Int. J. Mol. Med. 1(1), 117-119 (1998
17. Carod J-F, Ratsitorahina M, Raherimandimby H, Hincky Vitrat V, Ravaolimalala Andrianaja V, Contet-Audonneau N. Outbreak of Tinea capitis and corporis in a primary school in Antananarivo, Madagascar. J. Infect. Dev. Ctries. 5(10), 732-736 (2011
18. Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. Br. J. Dermatol. 143, 53-38 (2000
19. Russell AD, Day MJ. Antibacterial activity of chlorhexidine. J. Hosp. Infect. 25(4), 229-238 (1993
20. Elbaze P, Ortonne JP. [Practical use of antiseptics in dermatology]. Ann. Dermatol. Venereol. 116(1), 63-71 (1989
21. Stickler DJ, Thomas B. Antiseptic and antibiotic resistance in Gram-negative bacteria causing urinary tract infection. J. Clin. Pathol. 33(3), 288-296 (1980
22. Hegstad K, Langsrud S, Lunestad BT, Scheie AA, Sunde M, Yazdankhah SP. Does the wide use of quaternary ammonium compounds enhance the selection and spread of antimicrobial resistance and thus threaten our health? Microb. Drug Resist. 16(2), 91-104 (2010
23. Vigeant P, Loo VG, Bertrand C et al. An outbreak of Serratia marcescens infections related to contaminated chlorhexidine. Infect. Control Hosp. Epidemiol. 19(10), 791-794 (1998
24. Nakashima AK, McCarthy MA, Martone WJ, Anderson RL. Epidemic septic arthritis caused by Serratia marcescens and associated with a benzalkonium chloride antiseptic. J. Clin. Microbiol. 25(6), 1014-1018 (1987
25. Tiwari TS, Ray B, Jost KC Jr et al. Forty years of disinfectant failure: Outbreak of postinjection Mycobacterium abscessus infection caused by contamination of benzalkonium chloride. Clin. Infect. Dis. 36(8), 954-962 (2003
26. Coates D. Sporicidal activity of sodium dichloroisocyanurate, peroxygen and glutaraldehyde disinfectants against Bacillus subtilis. J. Hosp. Infect. 32(4), 283-294 (1996
27. Sagripanti JL. Metal-based formulations with high microbicidal activity. Appl. Environ. Microbiol. 58(9), 3157-3162 (1992
28. Martin L, Vaillant L. Antiseptiques. In: Thérapeutique Dermatologique. Médecine-Science Flammarion, Paris, France, 951-958 (2001
29. Fleurette J, Freney J, Reverdy ME. Les alcohols. In: Antisepsie et Désinfection. ESKA, Paris, France, 252-267 (1995
30. Gottardi W. The uptake and release of molecular iodine by the skin: Chemical and bactericidal evidence of residual effects caused by povidone-iodine preparations. J. Hosp. Infect. 29(1), 9-18 (1995
31. Harke HP. [Octenidine dihydrochloride, properties of a new antimicrobial agent]. Zentralbl. Hyg. Umweltmed. 188(1-2), 188-193 (1989
32. Tietz A, Frei R, Dangel M et al. Octenidine hydrochloride for the care of central venous catheter insertion sites in severely immunocompromised patients. Infect. Control Hosp. Epidemiol. 26(8), 703-707 (2005
33. Gordon J. Clinical significance of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in UK hospitals and the relevance of povidone-iodine in their control. Postgrad. Med. J. 69(Suppl. 3), S106-S116 (1993
34. Russell AD. Plasmids and bacterial resistance to biocides. J. Appl. Microbiol. 83(2), 155-165 (1997
35. Österlund A, Kahlmeter G, Haeggman S, Olsson-Liljequist B; Swedish Study Group on Fusidic Acid Resistant S. Aureus. Staphylococcus aureus resistant to fusidic acid among Swedish children: A follow-up study. Scand. J. Infect. Dis. 38(5), 332-334 (2006
36. Österlund A, Eden T, Olsson-Liljequist B, Haeggman S, Kahlmeter G. Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid. Scand. J. Infect. Dis. 34(10), 729-734 (2002
37. George A, Rubin G. A systematic review and meta-analysis of treatments for impetigo. Br. J. Gen. Pract. 53(491), 480-487 (2003
38. Dhurkin SR, Selva D, Huilgol SC, Guy S, Leibovitch I. Recurrent staphylococcal conjunctivitis associated with facial impetigo contagiosa. Am. J. Ophthalmol. 141(1), 189-190 (2006
39. Szepetiuk G, Henry F, Pierard GE. Comparative study of the efficacy of fusidic acid and povidone iodine in childhood impetigo. J. Pediatr. Infect. Dis. 1, 219-223 (2006
40. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am. J. Infect. Control 27(2), 97-132; quiz 133-134; discussion 196 (1999
41. Rotter ML, Larsen SO, Cooke EM et al. A comparison of the effects of preoperative whole-body bathing with detergent alone and with detergent containing chlorhexidine gluconate on the frequency of wound infections after clean surgery. The European Working Party on Control of Hospital Infections. J. Hosp. Infect. 11(4), 310-320 (1988
42. Lanker Klossner B, Widmer HR, Frey F. Nondevelopment of resistance by bacteria during hospital use of povidone-iodine. Dermatology 195(Suppl. 2), S10-S13 (1997
43. Goldenheim PD. In vitro efficacy of povidone-iodine solution and cream against methicillin-resistant Staphylococcus aureus. Postgrad. Med. J. 69(Suppl. 3), S62-S65 (1993
44. Stickler DJ. Chlorhexidine resistance in Proteus mirabilis. J. Clin. Pathol. 27(4), 284-287 (1974
45. Mayer S, Boos M, Beyer A, Fluit AC, Schmitz FJ. Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 47(6), 896-897 (2001
46. Skurray RA, Rouch DA, Lyon BR et al. Multiresistant Staphylococcus aureus: Genetics and evolution of epidemic Australian strains. J. Antimicrob. Chemother. 21(Suppl. C), 19-39 (1988
47. Lowbury EJ, Lilly HA, Bull JP. Methods for disinfection of hands and operation sites. Br. Med. J. 2(5408), 531-536 (1964
48. Reverdy ME, Martra A, Allaert FA, Nony P, Freney J. [Kinetics of bactericidal activity of PVP-I solution dermal on the resident flora of the elbow, after application of 15 or 30 seconds]. Médecine et Maladies Infectieuses 27, 711-714 (1997
49. Reverdy ME, Martra A, Stamm C, Claudy A, Allaert FA, Verriere JL. [Bactericidal activity of pvp-i alcoholic solution in comparison with the pvp-i dermal solution after single application on the resident flora of the elbow in healthy subjects evaluating tolerance after repeated applications for seven days]. Hygiènes 8(1), 34-38 (2000
50. Nagasawa M, Hayashi H, Nakayoshi T. In vitro evaluation of skin sensitivity of povidone-iodine and other antiseptics using a three-dimensional human skin model. Dermatology 204(Suppl. 1), S109-S113 (2002
51. Quatresooz P, Xhauflaire-Uhoda E, Pierard-Franchimont C, Pierard GE. Regional variability in stratum corneum reactivity to antiseptic formulations. Contact Dermatitis 56(5), 271-273 (2007
52. Cherry GW. Iodine revisited. Eur. Tissue Repair Soc. 4(1), 6-13 (1997
53. Lachapelle JM. Allergic contact dermatitis from povidone-iodine: A re-evaluation study. Contact Dermatitis 52(1), 9-10 (2005
54. Wiwanitkit V. Povidone iodine irritant dermatitis. Indian J. Pharmacol. 42(1), 55 (2010
55. Murthy MB, Krishnamurthy B. Severe irritant contact dermatitis induced by povidone iodine solution. Indian J. Pharmacol. 41(4), 199-200 (2009
56. Velázquez D, Zamberk P, Suárez R, Lázaro P. Allergic contact dermatitis to povidone-iodine. Contact Dermatitis 60(6), 348-349 (2009
57. Kara A, Tezer H, Devrim I, Cengiz AB, Secmeer G. Chemical burn: A risk with outdated povidone iodine. Pediatr. Dermatol. 24(4), 449-450 (2007
58. Contact Dermatitis (5th Edition). Johansen JD, Frosch PJ, Lepoittevin JP (Eds). Springer, Heidelberg, Germany (2011
59. Brockow K, Christiansen C, Kanny G et al. Management of hypersensitivity reactions to iodinated contrast media. Allergy 60(2), 150-158 (2005
60. Pecquet C. [Allergy to iodine]. Ann. Dermatol. Venereol. 130(8-9 Pt 1), 795-798 (2003
61. Aalto-Korte K, Makinen-Kiljunen S. Symptoms of immediate chlorhexidine hypersensitivity in patients with a positive prick test. Contact Dermatitis 55(3), 173-177 (2006
62. Weitz NA, Lauren CT, Weiser JA et al. Chlorhexidine gluconate-impregnated central access catheter dressings as a cause of erosive contact dermatitis: A report of 7 cases. JAMA Dermatol. 149(2), 195-199 (2013
63. Chong YY, Caballero MR, Lukawska J, Dugué P. Anaphylaxis during general anaesthesia: One-year survey from a British allergy clinic. Singapore Med. J. 49(6), 483-487 (2008
64. Lineaweaver W, Howard R, Soucy D et al. Topical antimicrobial toxicity. Arch. Surg. 120(3), 267-270 (1985
65. Cooper ML, Laxer JA, Hansbrough JF. The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J. Trauma 31(6), 775-782; discussion 782-774 (1991
66. Gilchrist B. Wound care. Should iodine be reconsidered? Nurs. Times 93(32), 70-71, 74-76 (1997
67. Fumal I, Braham C, Paquet P, Pierard-Franchimont C, Pierard GE. The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: A proof-of-concept study. Dermatology 204(Suppl. 1), S70-S74 (2002
68. Mayer DA, Tsapogas MJ. Povidone-iodine and wound healing: A critical review. Wounds 5(1), 14-23 (1993
69. Capriotti K, Capriotti JA. Topical iodophor preparations: Chemistry, microbiology, and clinical utility. Dermatol. Online J. 18(11), 1 (2012
70. Darouiche RO, Wall MJ Jr, Itani KM et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N. Engl. J. Med. 362(1), 18-26 (2010
71. Jarral OA, McCormack DJ, Ibrahim S, Shipolini AR. Should surgeons scrub with chlorhexidine or iodine prior to surgery? Interact. Cardiovasc. Thorac. Surg. 12(6), 1017-1021 (2011
72. Lee I, Agarwal RK, Lee BY, Fishman NO, Umscheid CA. Systematic review and cost analysis comparing use of chlorhexidine with use of iodine for preoperative skin antisepsis to prevent surgical site infection. Infect. Control Hosp. Epidemiol. 31(12), 1219-1229 (2010
73. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: A meta-analysis. Ann. Intern. Med. 136(11), 792-801 (2002
74. Macias JH, Arreguin V, Munoz JM, Alvarez JA, Mosqueda JL, Macias AE. Chlorhexidine is a better antiseptic than povidone iodine and sodium hypochlorite because of its substantive effect. Am. J. Infect. Control 1. doi:10.1016/j.ajic.10.002 (2013) (Epub ahead of print
75. Mimoz O, Karim A, Mercat A et al. Chlorhexidine compared with povidone-iodine as skin preparation before blood culture: A randomized, controlled trial. Ann. Intern. Med. 131(11), 834-837 (1999
76. Traoré O, Dubray C, Schuller MP, Laveran H. Comparison of the in vivo bactericidal efficacy of alcoholic povidone iodine versus alcoholic chlorhexidine for operation area disinfection. Hygiénes 12(4), 431-436 (2004
77. Swenson BR, Hedrick TL, Metzger R, Bonatti H, Pruett TL, Sawyer RG. Effects of preoperative skin preparation on postoperative wound infection rates: A prospective study of 3 skin preparation protocols. Infect. Control Hosp. Epidemiol. 30(10), 964-971 (2009
78. Maiwald M, Chan ES. The forgotten role of alcohol: A systematic review and meta-analysis of the clinical efficacy and perceived role of chlorhexidine in skin antisepsis. PLoS ONE 7, e44277 (2012
79. Parienti JJ, du Cheyron D, Ramakers M et al. Alcoholic povidone-iodine to prevent central venous catheter colonization: A randomized unit-crossover study. Crit. Care Med. 32(3), 708-713 (2004
80. Dumville JC, McFarlane E, Edwards P, Lipp A, Holmes A. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst. Rev. 3, CD003949 (2013
81. Smerdely P, Lim A, Boyages SC et al. Topical iodine-containing antiseptics and neonatal hypothyroidism in very-low-birthweight infants. Lancet 2(8664), 661-664 (1989
82. Parravicini E, Fontana C, Paterlini GL et al. Iodine, thyroid function, and very low birth weight infants. Pediatrics 98(4 Pt 1), 730-734 (1996
83. Gordon CM, Rowitch DH, Mitchell ML, Kohane IS. Topical iodine and neonatal hypothyroidism. Arch. Pediatr. Adolesc. Med. 149(12), 1336-1339 (1995
84. Brown RS, Bloomfield S, Bednarek FJ, Mitchell ML, Braverman LE. Routine skin cleansing with povidone-iodine is not a common cause of transient neonatal hypothyroidism in North America: A prospective controlled study. Thyroid 7(3), 395-400 (1997
85. Rooman RP, Du Caju MV, De Beeck LO, Docx M, Van Reempts P, Van Acker KJ. Low thyroxinaemia occurs in the majority of very preterm newborns. Eur. J. Pediatr. 155(3), 211-215 (1996